Trial · NCT01831804
Adverse events63
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 63
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Infected skin ulcer | Infections and infestations | Placebo HVT (Cohort 1) | 0 | 4 | 0 |
| other | Infected skin ulcer | Infections and infestations | A/B (Cohort 1) | 0 | 9 | 0 |
| other | Infected skin ulcer | Infections and infestations | Placebo DFU SD (Cohort 2, 3, 4) | 0 | 3 | 0 |
| other | Infected skin ulcer | Infections and infestations | C (Cohort 2) | 0 | 5 | 0 |
| other | Infected skin ulcer | Infections and infestations | D (Cohort 3) | 0 | 5 | 0 |
| other | Infected skin ulcer | Infections and infestations | E (Cohort 4) | 0 | 3 | 0 |
| other | Infected skin ulcer | Infections and infestations | Placebo DFU RD (Cohort 5) | 1 | 4 | 1 |
| other | Infected skin ulcer | Infections and infestations | R1r (Cohort 5) | 0 | 26 | 0 |
| other | Infected skin ulcer | Infections and infestations | Sr (Cohort 5) | 1 | 4 | 1 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo HVT (Cohort 1) | 0 | 4 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | A/B (Cohort 1) | 0 | 9 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo DFU SD (Cohort 2, 3, 4) | 0 | 3 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | C (Cohort 2) | 0 | 5 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | D (Cohort 3) | 0 | 5 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | E (Cohort 4) | 1 | 3 | 1 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo DFU RD (Cohort 5) | 1 | 4 | 1 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | R1r (Cohort 5) | 0 | 26 | 0 |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Sr (Cohort 5) | 0 | 4 | 0 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | Placebo HVT (Cohort 1) | 0 | 4 | 0 |
| other | Nasal congestion | Respiratory, thoracic and mediastinal disorders | A/B (Cohort 1) | 1 | 9 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01831804/events